Immunopathogenesis and therapy of cutaneous T cell lymphoma. - Wikidata - wikimedia - TriplyDB

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

http://www.wikidata.org/entity/Q33726963

about

Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets Primary cutaneous lymphomas: diagnosis and treatment Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat.Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach.The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications A mouse model for the Sézary syndrome.Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis.Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells.Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.Narrowband ultraviolet B phototherapy of early stage mycosis fungoides in korean patients.In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.Therapeutic Toll-like receptor agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome Serum Vitamin D and Vitamin D Receptor Gene Polymorphism in Mycosis Fungoides Patients: A Case Control Study.Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma Mycosis Fungoides: Tumour d'emblee.Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndrome Classification and treatment of rare and aggressive types of peripheral T-cell/natural killer-cell lymphomas of the skin.Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.Correlation between mycosis fungoides and pregnancy Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.

P2860

Q26746551-CFA1940F-649C-47DD-AD6C-5236439683A0 Q26772207-C9E1503A-8CC1-48D7-8BAB-5BD39642E991 Q33385966-85517301-73CA-4C0A-85C0-BBFA64115121 Q33386623-B06A38E7-919C-4075-B1A7-7CF28E7850D3 Q33737957-8173E9FC-8FAD-454A-A72E-7B82BBBAEED4 Q33746059-3C2FC5F5-715A-4A77-B229-E99B3CC1E59C Q33751820-771964D8-47E8-48FF-8F42-32D1EC2E6CB5 Q33930161-23883B3B-4497-47CF-B2C3-3CE37467C989 Q33942696-852DCC26-8D20-4A8A-952F-CA22990FF1DC Q33987080-AA24383A-6CA4-4FE4-AE83-C2E2872B65F2 Q34052608-6F628CE8-9057-45A1-90E1-E308914DFE1C Q34154516-48EBA88F-4A6A-4EF4-B153-5403E54017CE Q34413695-8CC7595D-C43D-4102-8990-AEF86F625DD8 Q34672100-1C43F043-5177-431F-8387-9532BE49C204 Q35053428-2B086E54-93DD-4563-B1E7-B4C6879FDA9D Q35105819-1B6EE442-8CE0-44C1-8531-204660F2C98F Q35186682-CC950FF0-14ED-4921-A3FD-EC4B1DDDF709 Q35584244-81FB7916-CFD7-4E0E-A5A7-192A957C629E Q35590358-D64FCB4B-A982-4CB2-9BD5-9B815C87ACFF Q35669197-A26B80B3-2CA0-4FC5-9755-1354719ED203 Q35751101-A69DF96B-7C12-4291-B004-390CE3491F50 Q35920787-F91884C2-8D5A-427C-9D33-59BDB1F8A9F0 Q36059635-E9EA279D-0687-47EC-8DF8-E87D1B42B0D7 Q36059716-DDE05992-FB62-454B-9777-9D1243C08D75 Q36070459-819AC2BC-BD0D-4A31-AFC0-086DC3DD9ACE Q36349486-7B8A9656-5803-4377-AB59-898FF31FDA78 Q36626781-E67C07E6-5A34-4944-91D9-9308973DC123 Q36771221-B426104E-6C97-47D8-9F82-9A74395379E3 Q36793430-37EBC546-02BE-4F51-AFF8-C00EEDD018DB Q36808610-C7DA4E2A-8CDE-46EB-812C-3EACCD64BB5F Q37025122-1BA10472-5AE8-4727-A0F6-FB688241D106 Q37052602-D8AE33C5-F55D-412D-A28D-2B853C793D71 Q37139517-D3A75938-D9C3-43EA-AA19-724D5778CD89 Q37160300-740D15E6-3F72-4BAB-81E3-338841A17F6D Q37237464-2E0E82FE-B7EE-4CD2-865B-F6D7C7603CC0 Q37291124-1B3E5740-0858-4D9D-93D0-BF74A90AC891 Q37509450-8700B9FB-A978-4FC6-A76F-1BACE5999EE6 Q37609458-4787E56B-B125-4859-9FFA-C9AE0AA48E76 Q37688819-E4A2BFFE-A224-4948-B073-C58AB489A946 Q37698501-3FE43E29-8380-4369-9452-DD88AB5F64C0

P2860

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

http://www.wikidata.org/entity/Q33726963

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

@ast

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

@en

type

label

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

@ast

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

@en

prefLabel

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

@ast

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

@en

P1433

Q33726963-A0B736EA-CC55-4745-9161-1E6972D3B1FC

P1476

Q33726963-97FCFBD5-B9AB-4489-89C4-8237415CD69D

P2093

Q33726963-028F057A-CCD1-4B32-9E7E-9AFEC387807C

Q33726963-686FB897-F094-4CCE-A154-230B7350A9AD

Q33726963-71038C03-3296-4C08-8539-90571E7F4763

Q33726963-A7074908-0F91-485C-9F40-03E802B80FA3

Q33726963-B11F77F8-B773-41DC-9A5C-CF5F67057267

Q33726963-B175906F-B0A6-40F3-A059-F6BFE960E77B

Q33726963-DC2764F9-9C23-4C56-A88B-315C8A2B2FA7

Q33726963-DC76DEEC-E921-40C4-8325-B873743BF4DA

Q33726963-F38C8826-CAEB-4EEB-BD3C-B772A2E434E7

Q33726963-F529E071-4F16-4BCB-B196-0D2F93014B5E

P2860

Q33726963-001478A2-3D73-49B7-A165-4C2FD668061F

Q33726963-00B7FD21-1E9C-446D-838B-1DCA8BF89906

Q33726963-0893E4AB-8639-4DF1-A52C-21662D703A2C

Q33726963-08FF7125-E126-4985-8ADA-DBA1C9C135B7

Q33726963-091C0291-9537-413D-BF3E-B336711B9D86

Q33726963-0AAB309A-3585-481B-BCEF-541ED8D84831

Q33726963-0B06474A-2799-4185-B503-60D474919965

Q33726963-0D7ABB86-A62F-4BC7-9ED5-9C5CA0C96637

Q33726963-154B2407-360E-48C6-97D1-CB9FE6721AE8

Q33726963-1615A952-1A94-487F-BD9C-B453F4B7E683

P304

Q33726963-AA047A02-FB7E-4725-8A21-D9CF07D2689F

P31

Q33726963-5EB79233-8CB9-496B-8EF6-16B5E12DDC10

P356

Q33726963-47B4F830-ADD4-4715-9018-169B27C56121

P407

Q33726963-2E248C8A-F776-4EB3-8B1C-8232CEA9585B

P433

Q33726963-FB688D52-94ED-41EA-B628-B6F2145A220E

P478

Q33726963-B2C5F26F-1753-4AB9-8DEE-F188ECDF9A83

P577

Q33726963-872F43C2-6506-4D53-A9AB-DBC6DBC6CF4E

P698

Q33726963-9842E0F1-A583-44FC-A9AD-5BDB4EC090A4

P932

Q33726963-6069423B-A9FA-4D33-A265-32D67E498BB2

P356

P1433

Journal of Clinical Investigation

P1476

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

@en

P2093

Alain H Rook

http://www.w3.org/2001/XMLSchema#string

Bernice M Benoit

http://www.w3.org/2001/XMLSchema#string

Carmela C Vittorio

http://www.w3.org/2001/XMLSchema#string

Ellen J Kim

http://www.w3.org/2001/XMLSchema#string

Jacqueline M Junkins-Hopkins

http://www.w3.org/2001/XMLSchema#string

Louise C Showe

http://www.w3.org/2001/XMLSchema#string

Maria Wysocka

http://www.w3.org/2001/XMLSchema#string

Ravi Ubriani

http://www.w3.org/2001/XMLSchema#string

Sara Newton

http://www.w3.org/2001/XMLSchema#string

Stephen Hess

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells

Improved detection of clonality in cutaneous T-cell lymphomas using laser capture microdissection.

Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells.

Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

Immune surveillance in the skin: mechanisms and clinical consequences.

Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses.

Cutaneous T cell lymphoma: the helping hand of dendritic cells.

Molecular genetics of cutaneous lymphomas.

P304

798-812

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI24826

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15841167

http://www.w3.org/2001/XMLSchema#string

P932

1070436

http://www.w3.org/2001/XMLSchema#string